USPTO trademark

ILIPASE

RegisteredUSPTOWord markClass 5

"ILIPASE" is a word mark owned by Alcresta Therapeutics, Inc., filed at the USPTO on January 22, 2013. It is registered and covers class 5 (Pharmaceuticals).

Get this data via the API
Official USPTO record
ILIPASE trademark as filed
As filed with the USPTO
Status
Registered
Since June 10, 2024
Filed
January 22, 2013
Registered
December 12, 2017
Expires
Not recorded
Application no.
85829579
Registration no.
5355288
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns ILIPASE

The owner and representative on file with the office.

Owner

Alcresta Therapeutics, Inc.

Waltham, United States

Representative

Perry J. Viscounty, Esq.

Latham & Watkins LLP

Goods and services

What the mark covers

The products and services ILIPASE is filed for, grouped by Nice class.

  • medical nutritional formula, namely, formula for use as a nutritional supplement, dietary supplement and food supplement; infant formula; [ dietetic foods adapted for medical use; ] enzymes; [ dietary and nutritional supplements; ] pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, [ metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and wound healing, mental illness, pulmonary, muscular and respiratory ] diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of acceptance of sec. 8 & 15 - e-mailed
  2. Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
  3. Case assigned to post registration paralegal
  4. Assignment of ownership not updated automatically
  5. Teas section 8 & 15 received
  6. Teas change of correspondence received
  7. Attorney/dom.rep.revoked and/or appointed
  8. Teas revoke/app/change addr of atty/dom rep received
  9. Applicant/correspondence changes (non-responsive) entered
  10. Teas change of owner address received

10 earlier steps on the official record.

FAQ

About ILIPASE

Who owns the trademark "ILIPASE"?

The USPTO trademark "ILIPASE" (application 85829579) is owned by Alcresta Therapeutics, Inc.

What is the status of "ILIPASE"?

Its status at the USPTO is: registered.

When was "ILIPASE" registered?

It was registered on December 12, 2017.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ILIPASE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2d4a-e9be-7075-bd4a-9dde28fd6e76
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2d4a-e9be-7075-bd4a-9dde28fd6e76",
  "object": "trademark",
  "mark_text": "ILIPASE",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "85829579",
  "filing_date": "2013-01-22",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "ALCRESTA THERAPEUTICS, INC.",
      "entity_id": null
    }
  ]
}